Arab Pharmaceuticals (ADCI) Key Statistics
25 reported figures for Arab Pharmaceuticals — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 3.5B
- P/E (trailing)
- 15.25
- P/B
- 5.64
- Dividend yield
- 2.86%
Income (latest fiscal year)
- Revenue
- EGP 1.12B
- Net income
- EGP 198.93M
- EBITDA
- EGP 358.51M
- Free cash flow
- EGP -64.04M
- Profit margin
- 17.79%
Balance sheet
- Total assets
- EGP 1.32B
- Total debt
- EGP 512.16M
- Book value
- EGP 619.74M
Growth
- Revenue growth
- 42.35%
- Profit growth
- 125.18%
- EPS growth
- 125.18%
Per share
- EPS (fiscal year)
- 16.58
- Book value per share
- 51.65
- Dividend per share
- 8.333
- Return on equity
- 36.9%
- Return on assets
- 16.2%
Technical
- RSI (14)
- 50.8
- 50-day moving average
- EGP 274.78
- 200-day moving average
- EGP 212.28
- Beta (1Y)
- 0.33
Shares
- Shares outstanding
- 12M
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.